MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2021 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
66.6 M |
Market Cap[1] |
$ 949 M |
EBITDA (LTM) |
$ 101 M |
P/E (LTM) |
41.382353 |
P/S (LTM) |
1.650065 |
EPS (LTM) |
0.34 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Castle Biosciences
CSTL
|
$ 34.37 | 3.68 % | $ 996 M | Nasdaq Global Market,SPB | USA |
 |
Guardant Health
GH
|
$ 166.66 | 2.5 % | $ 20.9 B | Nasdaq Global Select Market,SPB | USA |
 |
RadNet
RDNT
|
$ 68.41 | -1.78 % | $ 5.14 B | Nasdaq Global Select Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 3.68 | -9.8 % | $ 14.7 M | Nasdaq Capital Market |  Israel |
 |
DexCom
DXCM
|
$ 80.26 | -6.39 % | $ 31.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Senseonics Holdings
SENS
|
$ 7.97 | -2.92 % | $ 333 M | NYSE American | USA |
 |
Illumina
ILMN
|
$ 282.86 | 5.57 % | $ 43.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market |  Schweiz |
 |
VolitionRx Limited
VNRX
|
$ 0.17 | -2.63 % | $ 21.4 M | NYSE American |  Singapore |
 |
Waters Corporation
WAT
|
$ 457.47 | 3.31 % | $ 27.2 B | NYSE,SPB | USA |
 |
BioNano Genomics
BNGO
|
$ 1.25 | 0.4 % | $ 6.81 M | Nasdaq Capital Market,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 185.25 | 6.35 % | $ 14.5 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
ENDRA Life Sciences
NDRA
|
$ 4.68 | 6.24 % | $ 3.68 M | Nasdaq Global Select Market | USA |
 |
OPKO Health
OPK
|
$ 1.6 | -3.61 % | $ 1.2 B | Nasdaq Global Select Market | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 694.02 | 0.97 % | $ 262 B | NYSE,SPB | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 149.13 | 4.51 % | $ 8.92 B | Nasdaq Global Select Market,SPB | USA |
 |
Exagen
XGN
|
$ 7.88 | 6.34 % | $ 170 M | Nasdaq Global Market | USA |
 |
Sotera Health Company
SHC
|
$ 17.77 | -0.89 % | $ 5.05 B | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 413.38 | 1.84 % | $ 56.5 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
$ 50.0 | 2.27 % | $ 10.9 B | NYSE |  Niderland |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Trinity Biotech plc
TRIB
|
$ 7.75 | -0.51 % | $ 2.78 B | Nasdaq Global Select Market | Irlanda |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 238.93 | 0.83 % | $ 26.5 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
IDEXX Laboratories
IDXX
|
$ 553.48 | -0.8 % | $ 44.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Personalis
PSNL
|
$ 15.9 | -0.25 % | $ 1.42 B | Nasdaq Global Select Market | USA |
 |
Quidel Corporation
QDEL
|
$ 14.08 | -0.91 % | $ 593 M | Nasdaq Global Select Market,SPB | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 6.47 | 2.11 % | $ 28.6 M | Nasdaq Global Select Market | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Biomerica
BMRA
|
$ 1.71 | -0.51 % | $ 4.98 M | Nasdaq Capital Market | USA |
 |
Myriad Genetics
MYGN
|
$ 5.57 | 0.54 % | $ 516 M | Nasdaq Global Select Market,SPB | USA |
 |
Pacific Biosciences of California
PACB
|
$ 2.14 | 9.18 % | $ 642 M | Nasdaq Global Select Market,SPB | USA |
 |
Neuronetics
STIM
|
$ 2.01 | 1.52 % | $ 133 M | Nasdaq Global Select Market | USA |
 |
Agilent Technologies
A
|
$ 177.75 | 2.74 % | $ 50.5 B | NYSE,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 344.87 | 9.31 % | $ 17.1 B | NYSE,SPB | USA |
|
Biodesix
BDSX
|
$ 23.93 | 0.25 % | $ 181 M | Nasdaq Global Market | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 13.51 | 6.71 % | $ 142 M | Nasdaq Global Market | China |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.